Durgical
EN
Open the app

Vulvar neoplasia

  • Lesion

Vulvar cancer has two roads: HPV in younger women, chronic skin disease in older women. Paget disease and a gland tumour complete the list.

Updated

What it is

Squamous cell carcinoma is by far the most common vulvar cancer and arises through two different pathways. HPV-associated tumours grow from high-grade squamous intraepithelial lesions (usual VIN) in younger women, while HPV-independent tumours arise in older women on lichen sclerosus or lichen simplex chronicus through differentiated VIN and TP53 mutation. The vulva also has mammary-like glands that give rise to papillary hidradenoma, and its epidermis can harbour the large mucin-rich cells of extramammary Paget disease.

Structure

  • HSIL (usual VIN): full-thickness or near full-thickness immature atypical cells, sometimes with koilocytes; leads to basaloid or warty carcinomas with little keratin.
  • Differentiated VIN: subtle; the surface matures, but the basal cells are atypical and the rete ridges are elongated; leads to well-differentiated keratinizing carcinoma with keratin pearls.
  • Invasive carcinoma: an ulcer, nodule or exophytic mass on the labia; nests of squamous cells infiltrating the dermis.
  • Extramammary Paget: single cells and clusters of large cells with abundant pale cytoplasm spread through the epidermis; melanoma markers are negative.
  • Papillary hidradenoma: tubules and papillae lined by luminal cells over a myoepithelial layer, within a well-defined nodule of the labia or interlabial folds.

Step by step

  1. Pathway one: high-risk HPV infects the vulvar epithelium; viral E6 and E7 disable p53 and RB.
  2. The infected epithelium becomes HSIL and, over years and with cofactors such as smoking, invades as basaloid or warty carcinoma.
  3. Pathway two: chronic inflammation of lichen sclerosus or lichen simplex chronicus selects cells with TP53 mutation.
  4. These cells form differentiated VIN, which progresses quickly to keratinizing squamous cell carcinoma in older women.
  5. Both types spread first to the inguinal and femoral lymph nodes.

The two pathways to vulvar squamous cell carcinoma

FeatureHPV-associatedHPV-independent
Typical ageYounger to middle-agedOlder, postmenopausal
PrecursorHSIL (usual VIN)Differentiated VIN
Background skinOften multifocal HPV lesions in the lower tractLichen sclerosus or lichen simplex chronicus
Molecular driverHigh-risk HPV E6 and E7TP53 mutation
Carcinoma typeBasaloid or wartyKeratinizing, well differentiated
Marker patternp16 strong and diffusep53 abnormal, p16 negative

Markers

  • p16 (HPV-associated)
  • p53 (HPV-independent)
  • CK7 and mucin (Paget cells)
  • SOX10, melan-A (to exclude melanoma)

Clinical notes

  • Itch, a lump or an ulcer that does not heal; any persistent vulvar lesion in an older woman needs a biopsy.
  • Treatment is surgical with assessment of the groin nodes; recurrence is common in extramammary Paget because the cells spread beyond the visible edge.
  • HPV vaccination and smoking cessation reduce the HPV-associated pathway; follow-up of lichen sclerosus targets the other.

Test yourself

Think of the answer, then tap the question to see it.

What distinguishes differentiated VIN from usual VIN?

Differentiated VIN has atypia confined to the basal layer, arises on lichen sclerosus in older women and is HPV-independent; usual VIN is HPV-driven with atypia extending up the epithelium.

To which lymph nodes does vulvar carcinoma spread first?

The inguinal and femoral lymph nodes, then the pelvic nodes.

How does extramammary Paget disease of the vulva differ from Paget disease of the nipple?

Vulvar Paget is usually confined to the epidermis without an underlying carcinoma, while nipple Paget almost always comes from an underlying breast carcinoma.

Add to my cards (3)

More Pathology questions →

Elsewhere in DurgiPedia

Connections

← All of general pathology

Educational content on the mechanisms of disease; not a diagnostic or treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: Vulvar Cancer Treatment (PDQ®)–Health Professional Version (National Cancer Institute, 2026); Human Papillomavirus (StatPearls (NCBI Bookshelf), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.